MedTrace Logo

Psychometric Validation of Cognitive Endpoints

NCT01335633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-05-03

No results posted yet for this study

Summary

The study will entail cognitive assessment of a single cohort of patients with Multiple Sclerosis. Each subject will be assessed twice, approximately 45 days apart. There will be no intervention or control group. Each participant will have a caregiver capable of responding to a brief report of observations regarding neuropsychological skills and abilities in the patient.

Conditions

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY

  • Kessler Foundation

    lead OTHER

Principal Investigators

  • John DeLuca, Ph.D. · Kessler Foundation

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335633 on ClinicalTrials.gov